These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32840754)

  • 1. Association between nonsteroidal anti-inflammatory drug use and major adverse cardiovascular events in patients with end-stage renal disease: a population-based cohort study.
    Liao YC; Chang CC; Chen TL; Liu CC; Chen HH; Lee YW
    J Nephrol; 2021 Apr; 34(2):441-449. PubMed ID: 32840754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Risk of End-Stage Renal Disease (ESRD) Requiring Chronic Dialysis is Associated With Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Nationwide Case-Crossover Study.
    Chang YK; Liu JS; Hsu YH; Tarng DC; Hsu CC
    Medicine (Baltimore); 2015 Sep; 94(38):e1362. PubMed ID: 26402800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.
    Zhan M; Doerfler RM; Xie D; Chen J; Chen HY; Diamantidis CJ; Rahman M; Ricardo AC; Sondheimer J; Strauss L; Wagner LA; Weir MR; Fink JC;
    Am J Kidney Dis; 2020 Aug; 76(2):184-193. PubMed ID: 32317121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Risk of Cardiovascular Outcomes Between Topical and Oral Nonselective NSAIDs in Taiwanese Patients With Rheumatoid Arthritis.
    Lin TC; Solomon DH; Tedeschi SK; Yoshida K; Kao Yang YH
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Major Adverse Cardiovascular Events Associated with Concomitant Use of Antidepressants and Non-steroidal Anti-inflammatory Drugs: A Retrospective Cohort Study.
    Jeong HE; Oh IS; Kim WJ; Shin JY
    CNS Drugs; 2020 Oct; 34(10):1063-1074. PubMed ID: 32737794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk of nonsteroidal anti-inflammatory drugs in dialysis patients: a nationwide population-based study.
    Jo HA; Kim DK; Park S; Kim Y; Han SS; Yang BR; Choi SH; Kim MS; Lee J; Lee H; Lee JP; Lim CS; Kim YS; Joo KW
    Nephrol Dial Transplant; 2021 Apr; 36(5):909-917. PubMed ID: 31943085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction.
    Schjerning Olsen AM; Gislason GH; McGettigan P; Fosbøl E; Sørensen R; Hansen ML; Køber L; Torp-Pedersen C; Lamberts M
    JAMA; 2015 Feb; 313(8):805-14. PubMed ID: 25710657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between NSAID use and mortality risk in patients with end-stage renal disease: a population-based cohort study.
    Lai KM; Chen TL; Chang CC; Chen HH; Lee YW
    Clin Epidemiol; 2019; 11():429-441. PubMed ID: 31213924
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal transplantation delays major adverse cardiac events (MACEs) in patients with end-stage renal disease: A nationwide population-based study.
    Liao HT; Lin MC; Tsai CY; Hsu CY; Wu TH
    J Chin Med Assoc; 2018 Sep; 81(9):766-771. PubMed ID: 30173723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Risks of Nonsteroidal Anti-inflammatory Drugs on Cardiovascular Diseases: A Population-Based Cohort Study.
    Wan EYF; Yu EYT; Chan L; Mok AHY; Wang Y; Chan EWY; Wong ICK; Lam CLK
    J Clin Pharmacol; 2023 Jan; 63(1):126-134. PubMed ID: 36063443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and Bleeding Risks Associated With Nonsteroidal Anti-Inflammatory Drugs After Myocardial Infarction.
    Kang DO; An H; Park GU; Yum Y; Park EJ; Park Y; Jang WY; Kim W; Choi JY; Roh SY; Na JO; Kim JW; Kim EJ; Rha SW; Park CG; Seo HS; Choi CU
    J Am Coll Cardiol; 2020 Aug; 76(5):518-529. PubMed ID: 32731930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cardiovascular safety of nonsteroidal anti-inflammatory drugs in patients with hypertension: a population-based cohort study.
    Dong YH; Chang CH; Wu LC; Hwang JS; Toh S
    Br J Clin Pharmacol; 2018 May; 84(5):1045-1056. PubMed ID: 29468706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug use is associated with cancer risk reduction in chronic dialysis patients.
    Ou SM; Chen YT; Chao PW; Lee YJ; Liu CJ; Yeh CM; Chen TJ; Chen TW; Yang WC; Li SY
    Kidney Int; 2013 Jul; 84(1):198-205. PubMed ID: 23486520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of Early Predialysis Nephrology Care and Postdialysis Cardiovascular Events.
    Yang JY; Huang JW; Chen L; Chen YY; Pai MF; Tung KT; Peng YS; Hung KY
    Am J Kidney Dis; 2017 Aug; 70(2):164-172. PubMed ID: 28262267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced risk of NSAID-Induced adverse events with concomitant use of misoprostol (MICRO study).
    Munger MA; Nelson SD; Teng CC; Cheung AK; Sauer BC
    Pharmacotherapy; 2022 Jul; 42(7):540-548. PubMed ID: 35661392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of DPP-4 inhibitors on cardiovascular outcomes in patients with type 2 diabetes and end-stage renal disease.
    Chan SY; Ou SM; Chen YT; Shih CJ
    Int J Cardiol; 2016 Sep; 218():170-175. PubMed ID: 27236110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
    Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
    Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.